Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

Lane, JCE; Weaver, J; Kostka, K; Duarte-Salles, T; Abrahao, MTF; Alghoul, H; Alser, O; Alshammari, TM; Biedermann, P; Banda, JM; Burn, E; Casajust, P; Conover, MM; Culhane, AC; Davydov, A; DuVall, SL; Dymshyts, D; Fernandez-Bertolin, S; Fister, K; Hardin, J; Hester, L; Hripcsak, G; Kaas-Hansen, BS; Kent, S; Khosla, S; Kolovos, S; Lambert, CG; van der Lei, J; Lynch, KE; Makadia, R; Margulis, AV; Matheny, ME; Mehta, P; Morales, DR; Morgan-Stewart, H; Mosseveld, M; Newby, D; Nyberg, F; Ostropolets, A; Park, RW; Prats-Uribe, A; Rao, GA; Reich, C; Reps, J; Rijnbeek, P; Sathappan, SMK; Schuemie, M; Seager, S; Sena, AG; Shoaibi, A; Spotnitz, M; Suchard, MA; Torre, CO; Vizcaya, D; Wen, HN; de Wilde, M; Xie, JQ; You, SC; Zhang, L; Zhuk, O; Ryan, P; Prieto-Alhambra, D

Ryan, P (corresponding author), Janssen Res & Dev, Titusville, NJ 08560 USA.

LANCET RHEUMATOLOGY, 2020; 2 (11): E698

Abstract

Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid arthritis, has received much negative publicity for adverse events ......

Full Text Link